Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
Roswell Park Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
University of Alabama at Birmingham
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Neovii Biotech
National Heart, Lung, and Blood Institute (NHLBI)
University of Illinois at Chicago
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Indiana University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
University of Rochester
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Indiana University
University of Miami
Indiana University
Case Comprehensive Cancer Center
The Emmes Company, LLC
Mayo Clinic